Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-α, TGF-β1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-α) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-β1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-β1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fluoxetine, paroxetine, venlafaxine, and sertraline have been shown to have the potential to increase the levels of TGF-β1, which may contribute to their antidepressant effects. 391 , 392”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [392]
Experimental — accuracy not yet measuredIn the citing paper
“Sutcigil et al. found elevated serum levels of IL-12, which decreased after eight weeks of sertraline therapy [120].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1189 · Cited by 364
Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
The immune system, depression and the action of antidepressants
Leonard, B. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00155-5 · Cited by 333
Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
Mikova, O., Yakimova, R., Bosmans, E., Kenis, G., & Maes, M. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00081-5 · Cited by 305
Inflammatory Markers and Sleep Disturbance in Major Depression
Motivala, S. J., Sarfatti, A., Olmos, L., & Irwin, M. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000149259.72488.09 · Cited by 288
Cytokine Production and Serum Proteins in Depression
SEIDEL, A., AROLT, V., HUNSTIGER, M., RINK, L., BEHNISCH, A., & KIRCHNER, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03604.x · Cited by 244
Abnormal brachial artery flow-mediated vasodilation in young adults with major depression
Rajagopalan, S., Brook, R., Rubenfire, M., Pitt, E., Young, E., & Pitt, B. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01623-x · Cited by 241
Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001084 · Cited by 224
Th2 Cytokine Response in Major Depressive Disorder Patients before Treatment
Pavón, L., Sandoval-López, G., Eugenia Hernández, M., Loría, F., Estrada, I., Pérez, M., Moreno, J., Ávila, U., Leff, P., Antón, B., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.014 · Cited by 187
Kaestner, F., Hettich, M., Peters, M., Sibrowski, W., Hetzel, G., Ponath, G., Arolt, V., Cassens, U., & Rothermundt, M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.03.012 · Cited by 176
Cytokines and depression: fortuitous or causative association?
Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000572 · Cited by 174 · cited 1×
“Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2007, Article ID 76396, 6 pages doi:10.1155/2007/76396”
BackgroundInfluentialThe immunoregulatory effects of antidepressants
Maes, M. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.191 · Cited by 166
Different immune patterns in melancholic and non-melancholic major depression
Rothermundt, M., Arolt, V., Fenker, J., Gutbrodt, H., Peters, M., & Kirchner, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170058 · Cited by 157
The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150
Blood levels of cytokines in elderly patients with major depressive disorder
Brambilla, F., & Maggioni, M. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10005.x · Cited by 128
Cytokine production in major depressed patients before and after clomipramine treatment
Weizman, R., Laor, N., Podliszewski, E., Notti, I., Djaldetti, M., & Bessler, H. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91166-5 · Cited by 126
Maes, M. H. J., Stevens, W. J., DeClerck, L., Bridts, C. H., Peters, D., Schotte, C., & Cosyns, P. R. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90045-t · Cited by 109
Interleukin-1β and tumor necrosis factor-α in children with major depressive disorder or dysthymia
Brambilla, F., Monteleone, P., & Maj, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00315-4 · Cited by 107
Increased CD56+Natural Killer Cells and Related Cytokines in Major Depression
Seide, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., & Kirchner, H. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0012 · Cited by 104
Immune disorders in depression: higher T helper/T suppressor‐cytotoxic cell ratio
Maes, M. H. J., Stevens, W. S., DeClerck, L., Bridts, C. H., Peeters, D., Schotte, C., & Cosyns, P. R. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03292.x · Cited by 96
Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression
Carpenter, L. L., Heninger, G. R., Malison, R. T., Tyrka, A. R., & Price, L. H. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00460-3 · Cited by 79
Maes, M. H. J. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90652-1 · Cited by 63
Schlatter, J., Ortuño, F., & Cervera‐Enguix, S. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.06.004 · Cited by 48
Is depression associated with immune activation?
Natelson, B. H. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00118-9 · Cited by 34
Serotonin-Immune Interactions in Major Depression
Kubera, M., & Maes, M. H. J. (2000) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-59643-8_8 · Cited by 30
Is There Evidence for an Effect of Antidepressant Drugs on Immune Function?
Neveu, P. J., & Castanon, N. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_15 · Cited by 26
Kanba, S., Manki, H., Shintani, F., OHNO, Y., Yagi, G., & ASAI, M. (1998) · Psychological Medicine · doi:10.1017/s0033291797006454 · Cited by 18
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“391,392 Venlafaxine has also been reported to exert neuroprotection by increasing the production of FGF-2 and TGF-β 1 in astrocytes following stroke.”
BackgroundImmune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129
Metadata
- Authors
- Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., & Sengul, A.
- Affiliations
- Gülhane Askerî Tıp Akademisi (TR)
- Venue
- Clinical and Developmental Immunology
- Publisher
- Hindawi Limited
- Published
- 2007
- Volume
- 2007
- Pages
- 1-6
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC2248234
- OpenAlex
- W1998520631
- Cited by
- 315
- References
- 36
- Citations by year
- 2026: 2 · 2025: 15 · 2024: 19 · 2023: 13 · 2022: 9 · 2021: 26 · 2020: 24 · 2019: 16 · 2018: 14 · 2017: 21 · 2016: 28 · 2015: 11 · 2014: 28 · 2013: 17 · 2012: 16
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- AYBU AVESIS (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Gülhane Military Medical Academy
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, sertraline, cytokines, chemokines, inflammatory cytokines, anti-inflammatory cytokines, IL-12, IL-4, TNF-α, TGF-β1, MCP-1, immunomodulation, antidepressant effects, Th1/Th2 balance
- MeSH terms
- Adult, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interleukin-2, Male, Tumor Necrosis Factor-alpha, Interleukin-4, Cytokines, Interleukin-12, Chemokine CCL2, Sertraline, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.